Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1982-03-19
1983-12-20
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
424267, 424272, 548247, C07D41304, C07D41314, A61K 3142
Patent
active
044217528
ABSTRACT:
This disclosure describes compounds of the formula ##STR1## where R.sub.1 represents hydrogen, fluoro, chloro, lower alkyl having 1 to 4 carbon atoms or lower alkoxy having 1 to 4 carbon atoms, and
REFERENCES:
Mirsky, et al., "Insalinase Inhibitory Action . . . ", Chem. Abst. 51:15775(d), (1957).
Speeter, Merrill, "Reduction 3-Indolylcarbonyl Compounds . . . ", Chem. Abst. 52:12923(f), (1958).
Mashkovskii, et al., "Pharm. Study of Tryptamine . . . ", Chem. Abst. 81:9606(g), (1974).
Smith, et al., "Hypoglycemic Action of Tryptamine,", Chem. Abst. 87:16491t, (1977).
Brand Leonard J.
Nadelson Jeffrey
Daus Donald G.
Hendricks G.
Honor Robert S.
McGovern Thomas O.
Sandoz Inc.
LandOfFree
Isoxazolyl indolamines as hypoglycemics does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isoxazolyl indolamines as hypoglycemics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isoxazolyl indolamines as hypoglycemics will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-107337